Cyclacel Pharmaceuti (CYCC) Stock Price, Quote & News

Company Profile

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

Industry: Biotechnology

Sector: Healthcare

Phone: 60 9 08517 7330

Website: www.cyclacel.com

Address:

Level 10, Tower 11 Avenue 5, No. 8 Jalan Kerinchi, Kuala Lumpur, Malaysia

Viacheslav45 Sep. 9 at 9:48 AM

$CYCC Who here is holding what forecasts for speculation?

0 · Reply

StockSparker Sep. 5 at 8:36 PM

$CYCC Up 20% already! 🔥 Can't wait for Monday 🤑

0 · Reply

StockSparker Sep. 5 at 4:08 PM

$CYCC Looks bottomed out. Let's see 500%+! 🔥👀

0 · Reply

Viacheslav45 Sep. 4 at 8:54 PM

$CYCC

1 · Reply

NVDAMillionaire Sep. 3 at 1:43 PM

$CYCC Outstanding article that hits the mark on CYCC's current state. So if you want to refresh your CYCC insights or learn about CYCC from scratch, this is a must read. https://beyondspx.com/quote/CYCC/cyclacel-s-metamorphosis-a-radical-pivot-beyond-biotech-nasdaq-cycc#analysis

0 · Reply

Sw1ngb0t Sep. 2 at 2:12 PM

$INHD reminds of that time I tripled my position on $CYCC. This is also a 2 bagger

0 · Reply

StockSparker Aug. 29 at 4:22 PM

$CYCC Heating up 👀

0 · Reply

Sw1ngb0t Aug. 26 at 1:40 PM

$GXAI let er rip.... reminds of my $CYCC 2 bagger

0 · Reply

WallStVisions Aug. 24 at 11:27 PM

TRUG 1-for-50 reverse split just slashed the float to 0.8M shares. Expect squeeze mechanics to kick in when investors catch on. LaunchBox portable monitor and franchise rollouts (160+ units across 4 states, including Illinois) are now in full swing. Added AI tech muscle with the acquisition of mlSpatial priming their product suite (Apogee, E6 APEX, LaunchBox) for modernization. Nasdaq compliance restored, combined with a strategic $2M stock buyback, shows strong structural confidence. This is the kind of equation that builds stealth breakouts. $CYCU $CYCC $RSLS $IXHL …

0 · Reply

Henry_RatBastard_Hill Aug. 24 at 12:42 AM

$HOLO $TNXP $CYCC

0 · Reply

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

CYCCP

Aug 4, 2025, 6:50 PM EDT - 5 weeks ago

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB

CYCCP

Jul 15, 2025, 12:17 PM EDT - 7 weeks ago

Why Is Cyclacel Pharmaceuticals Stock Soaring On Tuesday?

CYCCP

Jul 7, 2025, 6:00 AM EDT - 2 months ago

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER

CYCCP

Jul 7, 2025, 6:00 AM EDT - 2 months ago

CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT

CYCCP

Jul 2, 2025, 9:00 AM EDT - 2 months ago

Cyclacel Pharmaceuticals Announces Stock Split

CYCCP

Jun 20, 2025, 4:30 PM EDT - 2 months ago

Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock

CYCCP

Jun 3, 2025, 4:15 PM EDT - 3 months ago

CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

CYCCP

May 15, 2025, 12:50 AM EDT - 4 months ago

CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

CYCCP

May 7, 2025, 9:00 AM EDT - 4 months ago

CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT

CYCCP

May 6, 2025, 6:00 AM EDT - 4 months ago

CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCHANGE AGREEMENT TO MAKE FITTERS SDN.

CYCCP

Apr 2, 2025, 4:05 PM EDT - 5 months ago

Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update

CYCCP

Mar 24, 2025, 7:30 AM EDT - 6 months ago

Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock

CYCCP

Feb 27, 2025, 1:38 PM EST - 6 months ago

Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership

CYCCP

Jan 3, 2025, 9:01 AM EST - 8 months ago

Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar

CYCCP

Dec 5, 2024, 4:05 PM EST - 9 months ago

Cyclacel Pharmaceuticals Announces Its Exploration of Potential Strategic Alternatives and Reduction of Operating Costs

CYCCP

Nov 14, 2024, 4:15 PM EST - 10 months ago

Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds

CYCCP

Nov 13, 2024, 12:22 PM EST - 10 months ago

Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds

CYCCP

Nov 12, 2024, 4:45 PM EST - 10 months ago

Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update

CYCCP

Oct 24, 2024, 9:15 AM EDT - 11 months ago

Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule

CYCCP

Oct 23, 2024, 9:15 AM EDT - 11 months ago

Cyclacel Pharmaceuticals Reports New Clinical Data from Ongoing, Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium

CYCCP

Oct 9, 2024, 9:15 AM EDT - 11 months ago

Cyclacel Pharmaceuticals to Present New Clinical Data From Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium

CYCCP

Sep 25, 2024, 9:15 AM EDT - 1 year ago

Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study

CYCCP

Sep 4, 2024, 9:15 AM EDT - 1 year ago

Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference

CYCCP

Sep 3, 2024, 9:15 AM EDT - 1 year ago

Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter

CYCCP

Aug 14, 2024, 8:18 PM EDT - 1 year ago

Cyclacel Pharmaceuticals, Inc. (CYCC) Q2 2024 Earnings Call Transcript

CYCCP

Aug 7, 2024, 9:15 AM EDT - 1 year ago

Cyclacel Pharmaceuticals to Release Second Quarter 2024 Financial Results

CYCCP

Jun 26, 2024, 9:15 AM EDT - 1 year ago

Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions

CYCCP

Jun 4, 2024, 8:00 AM EDT - 1 year ago

Cyclacel's Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting

CYCCP

May 14, 2024, 8:08 PM EDT - 1 year ago

Cyclacel Pharmaceuticals, Inc. (CYCC) Q1 2024 Earnings Call Transcript

CYCCP

May 8, 2024, 9:15 AM EDT - 1 year ago

Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results

CYCCP

May 2, 2024, 4:30 PM EDT - 1 year ago

Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules

CYCCP

Apr 30, 2024, 7:00 AM EDT - 1 year ago

Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

CYCCP

Apr 1, 2024, 9:15 AM EDT - 1 year ago

Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib's Potential as a Precision Medicine for Cancer

CYCCP

Mar 19, 2024, 6:09 PM EDT - 1 year ago

Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcript

CYCCP

Mar 19, 2024, 4:05 PM EDT - 1 year ago

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

CYCCP

Mar 13, 2024, 4:05 PM EDT - 1 year ago

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results

CYCCP

Mar 7, 2024, 9:15 AM EST - 1 year ago

Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024

CYCCP

Mar 6, 2024, 9:15 AM EST - 1 year ago

Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit

CYCCP

Feb 20, 2024, 9:15 AM EST - 1 year ago

Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference

CYCCP

Jan 30, 2024, 9:15 AM EST - 1 year ago

Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer

CYCCP

Jan 8, 2024, 9:15 AM EST - 1 year ago

Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement

CYCCP

Jan 2, 2024, 9:15 AM EST - 1 year ago

Cyclacel Pharmaceuticals to Present at Biotech Showcase 2024

CYCCP

Dec 22, 2023, 9:15 AM EST - 1 year ago

Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules

CYCCP

Dec 18, 2023, 9:00 AM EST - 1 year ago

Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CDKN2A, CDKN2B and MTAP Deletions

CYCCP

Dec 12, 2023, 4:05 PM EST - 1 year ago

Cyclacel Pharmaceuticals Announces Reverse Stock Split

CYCCP

Nov 30, 2023, 9:15 AM EST - 1 year ago

Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SEC

CYCCP

Nov 28, 2023, 5:15 PM EST - 1 year ago

Cyclacel Receives Notification of Deficiency From Nasdaq Regarding Timely Filing of Quarterly Report on Form 10-Q

CYCCP

Nov 13, 2023, 7:32 PM EST - 1 year ago

Cyclacel Pharmaceuticals, Inc. (CYCC) Q3 2023 Earnings Call Transcript

CYCCP

Nov 7, 2023, 9:15 AM EST - 1 year ago

Cyclacel Pharmaceuticals to Release Third Quarter 2023 Financial Results

CYCCP

Viacheslav45 Sep. 9 at 9:48 AM

$CYCC Who here is holding what forecasts for speculation?

0 · Reply

StockSparker Sep. 5 at 8:36 PM

$CYCC Up 20% already! 🔥 Can't wait for Monday 🤑

0 · Reply

StockSparker Sep. 5 at 4:08 PM

$CYCC Looks bottomed out. Let's see 500%+! 🔥👀

0 · Reply

Viacheslav45 Sep. 4 at 8:54 PM

$CYCC

1 · Reply

NVDAMillionaire Sep. 3 at 1:43 PM

0 · Reply

Sw1ngb0t Sep. 2 at 2:12 PM

$INHD reminds of that time I tripled my position on $CYCC. This is also a 2 bagger

0 · Reply

StockSparker Aug. 29 at 4:22 PM

$CYCC Heating up 👀

0 · Reply

Sw1ngb0t Aug. 26 at 1:40 PM

$GXAI let er rip.... reminds of my $CYCC 2 bagger

0 · Reply

WallStVisions Aug. 24 at 11:27 PM

0 · Reply

Henry_RatBastard_Hill Aug. 24 at 12:42 AM

$HOLO $TNXP $CYCC

0 · Reply

HarmonicHedge Aug. 23 at 10:44 AM

$CYCC Cyclacel Pharmaceuticals Inc is a clinical stage oncology company with funding challenges

0 · Reply

SDBiotechInvestor Aug. 22 at 7:15 PM

$CYCN - $CYCC did 1000% move, at its peak, after $1 million stock acquisition of a Malaysian sanitation company (LOL). What will an AI powered CNS device do for us?

1 · Reply

King_of_Bio Aug. 22 at 6:00 PM

$CYCC This stock is like watching a plane fall out the sky. You know where it's headed...and it ain't good. BAIL NOW - FINAL WARNING

1 · Reply

VarsityMack Aug. 21 at 9:31 PM

$CYCC 🚀🚀💪🏼

0 · Reply

123MONEYGUY Aug. 21 at 3:50 PM

$CYCC buy alert ⚠️ 📢 👀 😳 😍 😎 ⚠️

0 · Reply

MOUN4 Aug. 21 at 3:01 PM

$ZNB $AEMD $CYCC $BURU super bullish ! $ZNB Big Money sent the 777 buy signal twice in less than 30min . It s about to run ! Hold on to your shares …. !

0 · Reply

geffaxp Aug. 21 at 1:57 PM

$CYCC SCAM. RUN AWAY... SEE CHART FROM 2021.

0 · Reply

DarthGoat Aug. 21 at 1:07 PM

$CYCC $EAF $LZMH $XPON You placed orders on July 21 using EPEC data from my Substack — here’s the profit you could have made by August 21 just by placing buy orders at the EPEC entry prices right after the open, exactly like I do every morning. To get these entry prices each and every morning, email me at: [email protected] .

2 · Reply

TA_Kongen Aug. 20 at 8:24 AM

$NBY Ahh so this clown David Lazar again. He figured out you can keep doing this trick with taking positions in shell macro companies making a quick buck on the pump. What a sad individual. Should not be allowed imo. $CYCC $FIEE.

0 · Reply

ExecutiveEdge Aug. 20 at 4:08 AM

watch TGL Imagine two companies both starting treasure chests full of crypto. First was BMNR SBET they said, “we’re gonna keep Ethereum as our big savings account,” and the stock went from about $5 to $161 in just a few days. Now comes TGL they just started their own crypto treasure chest with $100 million ready to load up on Bitcoin, Ethereum, and stablecoins. But here’s the wild part: while BMNR already blasted off, TGL is still sitting almost AT THE BOTTOM, That means it hasn’t had its big move yet. It’s like watching the rocket still on the launch pad while the last one already flew to the moon. 🚀 $CYCC $QUBT $RGTI $DFDV !

0 · Reply

bahjatbern Aug. 19 at 9:46 AM

$CYCC to the moon hahahaha

0 · Reply

BigSqueezeComing Aug. 19 at 9:08 AM

$CYCC gappers

0 · Reply

Market Cap	15.94M
Revenue (ttm)	40,000.00
Net Income (ttm)	-11.21M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-28,025.00%
Debt to Equity Ratio	0.00

Volume	34,800
Avg Vol	2,254,335
Day's Range	N/A - N/A
Shares Out	2.24M
Stochastic %K	14%
Beta	0.15
Analysts	Hold
Price Target	$1.00